Company: GEHC
Filing Date: 2025-04-30
Form Type: 10-Q
Source: 0001932393-25-000014
Chunk: 87

Company: GE HealthCare Technologies Inc.
Filing Date: 2025-04-30
Form: 10-Q
Item: Item 1
Chunk 87
---
 March 3120252024 % change % organic* changeSegment revenuesImaging    $2,140$2,0624%5%AVS    1,2391,2271%3%PCS    7537471%2%PDx    6325996%8%Other(1)     1315Total revenues    $4,777$4,6503%4%

(1) Financial information not presented within the reportable segments, shown within the Other category, represents HealthCare Financial Services which does not meet the definition of an operating segment.

Revenues by RegionFor the three months ended March 3120252024 % changeUnited States and Canada (“USCAN”)    $2,237$2,0937%Europe, the Middle East, and Africa (“EMEA”)    1,1741,174—%China region    593597(1)%Rest of World    773785(2)%Total revenues    $4,777$4,6503%

For the three months ended March 31, 2025

Total revenues were $4,777 million, growing 3% as reported and 4% organically*. Sales of products increased 2% or $71 million with strong growth in USCAN, led by PDx and Imaging segment revenues. Sales of services increased 3% or $56 million primarily driven by growth in new and existing customer contractual agreements.

____________________

*Non-GAAP Financial Measure

29

Table of Contents                 

The segment revenues were as follows:

•Imaging segment revenues were $2,140 million, growing 4% or $77 million, with growth across all regions, led by Molecular Imaging and Computed Tomography (“MI/CT”) and Magnetic Resonance (“MR”) product lines;

•AVS segment revenues were $1,239 million, growing 1% or $12 million, with strength in the U.S. market largely offset by unfavorable foreign currency impacts and continued pressure in the China market.

•PCS segment revenues were $753 million, growing 1% or $6 million, driven by strength in the U.S., including growth in Monitoring Solutions, largely offset by declines in Anesthesia revenues due to market timing and unfavorable foreign currency impacts; and

•PDx segment revenues were $632 million, growing 6% or $33 million driven by continued growth in price and volume.

The regional revenues were as follows